SFX by Ex Libris Inc.

Title:	Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Source:	Nature [0028-0836] Alizadeh, Ash yr:2000

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Shipp, M. "Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning." Nature medicine 8.1 (2002): 68-74.
description	2.	van 't Veer, Laura J J. "Gene expression profiling predicts clinical outcome of breast cancer." Nature 415.6871 (2001): 530-6.
description	3.	Perou, T. "Molecular portraits of human breast tumours." Nature 406.6797 (2000): 747-52.
description	4.	Bertina, R M M. "Mutation in blood coagulation factor V associated with resistance to activated protein C." Nature 369.6475 (1994): 64-67.
description	5.	Rosenwald, A. "Gene expression profiling of diffuse large B-cell lymphoma." Leukemia & lymphoma 48.4 (2003): 669-7.
description	6.	van de Vijver, Marc J J. "A gene-expression signature as a predictor of survival in breast cancer." The New England journal of medicine 347.25 (2003): 1999-2009.
description	7.	Sorlie, T. "Gene Expression Patterns of Breast Carcinomas Distinguish Tumor Subclasses with Clinical Implications." Proceedings of the National Academy of Sciences of the United States of America 98.19 (2001): 10869-10874.
description	8.	Chang, Jenny C. "Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer." The lancet 362.9381 (2003): 362-9.
description	9.	Ye, Qing-Hai H. "Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning." Nature medicine 9.4 (2003): 416-423.
description	10.	Sorlie, T. "Repeated observation of breast tumor subtypes in independent gene expression data sets." Proceedings of the National Academy of Sciences of the United States of America 100.14 (2003): 8418-23.
description	11.	Bild, Andrea H H. "Oncogenic pathway signatures in human cancers as a guide to targeted therapies." Nature 439.7074: 353-357.
description	12.	Rosendaal, F R R. "[Recently discovered frequent cause of venous thrombosis: factor V Leiden, a mutated factor V, resistant against protein C inactivation]." Nederlands tijdschrift voor geneeskunde (1994): 1944-8.
description	13.	Lossos, Izidore S S. "Prediction of Survival in Diffuse Large-B-Cell Lymphoma Based on the Expression of Six Genes." The New England journal of medicine 350.18 (2004): 1828-1837.
description	14.	Bertina, R M M. "A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis." Blood 88.10: 3698-3703.
description	15.	Fan, C. "Concordance among gene-expression-based predictors for breast cancer." New England Journal of Medicine, The 355.6 (2006): 560-9.
description	16.	Hans, Alison H P. "Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray." Blood 103.1 (2004): 275-82.
description	17.	Rouzier, R. "Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy." Clinical cancer research 11.16 (2005): 5678-5685.
description	18.	Bertina, R. "Factor V Leiden and other coagulation factor mutations affecting thrombotic risk." Clinical Chemistry 1997. 1678-1683.
description	19.	Tholouli, E. "Imaging of multiple mRNA targets using quantum dot based in situ hybridization and spectral deconvolution in clinical biopsies." Biochemical and biophysical research communications 348.2 (2006): 628-636.
description	20.	Walport, M J J. "Factor V Leiden mutation and venous thrombosis." Lancet, The 345.8942 (1994): 132-3.